Company Profile

BillionToOne is a precision diagnostics company on a mission to make molecular diagnostics more powerful, efficient, and accessible for all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. Built on this technology, UNITY Complete® advances prenatal screening with direct fetal risk assessment from a single maternal blood sample, while Northstar delivers highly sensitive liquid biopsy tests to guide and monitor cancer treatment. Headquartered in Menlo Park, California, BillionToOne develops transformative diagnostics held to the highest quality standards.